Login
Research AI
Scans
Tools
Login
Home
Charts
Search
Watchlist
Products
All IPOs

KRM Ayurveda Ltd

HealthcareIPOSME
₹135 - 135
₹135 - 135

Our Company, established in 2019, is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. Presently, Company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Though KRM Ayurveda started off as a kidney hospital and it continues to provide specialized treatment for kidney disorders, the Company has widened its horizons in the past few years and has now evolved for various health disorders such as kidney disorder, Liver Cirrhosis, Diabetes, Fatty Liver, Arthritis etc. Company has marked its reach globally as well through Tele-Consultancy Services. Further, we focus on specialized segments within the medical and healthcare domain that address specific health issues and challenges, such as addiction, personal care, wellness, and related areas and for that we are engaged into trading of Ayurvedic medicine, oils and supplements.

Lot1,000Min Invest₹2,70,000Face Value₹10Issue Size₹77 CrFresh Issue₹77 CrListing Price₹172CMP₹239

Timeline

21 Jan
Bidding opens
23 Jan
Bidding closes
27 Jan
Allotment
28 Jan
Refund & demat credit
29 Jan
Listing

Subscription

Subscription opens once dates are announced

Reports

Offer Details

Terms

Issue Size₹77 Cr0.57 Cr shares
Fresh Issue₹77 Cr
Face Value₹10
Lot Size1,000 shares
ReservationQIB 49.83% · NII 15.07% · RETAIL 35.1%

Application Sizes

Retail₹2,70,0001-1 lots
sNII₹2,70,000from 2 lots
bNII₹10,80,000from 8 lots

Managers & Registrar

Lead ManagerNEXGEN Financial Solutions Pvt. Ltd.
RegistrarSkyline Financial Services Pvt

Ownership & Proceeds

Shareholding

CategoryPre IPOPost IPOPromoter Group92.16%67.29%Public7.84%32.71%

Objects of the Issue

  1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
  2. Purchase of CRM Software and Hardware Infrastructure
  3. Human Resources
  4. Repayment/Prepayment of loan
  5. Working Capital Requirement
  6. General Corporate Purpose

Financials

Profit & Loss

Financial YearFY23FY24FY25FY26
RevenueCr896777102
Operating ProfitCr1171931
OPM%12.310.924.530.0
PBTCr1051527
PATCr831120
EPS527489

Balance Sheet

Financial YearFY23FY24FY25FY26
Equity CapitalCr00021
ReservesCr8122493
BorrowingsCr2023310
Total AssetsCr394467122

Cash Flow

Financial YearFY23FY24FY25FY26
Operating Cash FlowCr4-131
Investing Cash FlowCr-230-8-31
Financing Cash FlowCr191637
Net Cash FlowCr0027

Strengths & Risks

Strengths · as stated in the DRHP
  • Designing and execution capabilities.
  • Experienced management team and a motivated and efficient work force.
  • Cordial relations with its consumers.
  • Quality assurance and control.
Strategies · as stated in the DRHP
  • Expansion of Domestic & International Market.
  • Conducting Training Courses for Therapists.
  • Regulatory Compliance and Certifications.
  • Distribution and Expansion.
Risks · as stated in the DRHP
  • The company's Registered Office and other hospital premises from where the company operates are not owned by the company. If the company are required to vacate the same, due to any reason whatsoever, the company's may adversely affect its business operations.
  • The Company has experienced, and may continue to experience, a higher rate of employee attrition in recent periods, including among frontline and technical staff.
  • Majority of its state wise revenues from operations for the last 3 years is majorly derived from the company's Top 2 States. Any adverse developments affecting its operations in this state could have an adverse impact on the company's revenue and results of operations.
  • The company's business is working capital intensive, and fluctuations or inadequate financing of its working capital requirements may adversely affect the company's business, financial condition, and results of operations.
  • The company is dependents on third-party transportation service providers for delivery of its raw materials and finished products. Any disruption in such transportation arrangements or increase in transportation costs may materially and adversely affect the company's business, financial condition, results of operations, and cash flows
  • Conflicts of interest may arise out of common business undertaken by the Company and its promoter.
Show all 65 risks